PA8459501A1 - PARASITICIDE FORMULATIONS - Google Patents

PARASITICIDE FORMULATIONS

Info

Publication number
PA8459501A1
PA8459501A1 PA19988459501A PA8459501A PA8459501A1 PA 8459501 A1 PA8459501 A1 PA 8459501A1 PA 19988459501 A PA19988459501 A PA 19988459501A PA 8459501 A PA8459501 A PA 8459501A PA 8459501 A1 PA8459501 A1 PA 8459501A1
Authority
PA
Panama
Prior art keywords
parasiticide formulations
parasiticide
formulations
parasitical
administer
Prior art date
Application number
PA19988459501A
Other languages
Spanish (es)
Inventor
Hiep Huatan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PA8459501A1 publication Critical patent/PA8459501A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION APORTA UN IMPLANTE SOLIDO QUE COMPRENDE AL MENOS UN COMPUESTO PARASITICIDA QUE TIENE UNA BAJA SOLUBILIDAD ACUOSA Y EXCIPIENTES DE COMPRESION ENTRE LOS QUE SE INCLUYE UN AGENTE DE RELLENO. LOS IMPLANTES DE ACUERDO CON LA INVENCION SON COMODOS DE ADMINISTRAR Y PROPORCIONAN UNA PROTECCION PROLONGADA FRENTE A PARASITOS.THE INVENTION PROVIDES A SOLID IMPLANT THAT INCLUDES AT LEAST ONE PARASITICAL COMPOUND THAT HAS A LOW AQUEOUS SOLUBILITY AND EXPRESSIONS OF COMPRESSION, INCLUDING A FILLING AGENT. IMPLANTS ACCORDING TO THE INVENTION ARE COMFORTABLE TO ADMINISTER AND PROVIDE PROLONGED PROTECTION AGAINST PARASITES.

PA19988459501A 1997-09-23 1998-09-17 PARASITICIDE FORMULATIONS PA8459501A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
PA8459501A1 true PA8459501A1 (en) 2000-05-24

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988459501A PA8459501A1 (en) 1997-09-23 1998-09-17 PARASITICIDE FORMULATIONS

Country Status (13)

Country Link
EP (1) EP1014970A1 (en)
JP (1) JP2001517622A (en)
AP (1) AP9801350A0 (en)
AR (1) AR013509A1 (en)
AU (1) AU9742298A (en)
BR (1) BR9812385A (en)
CA (1) CA2304283A1 (en)
GT (1) GT199800149A (en)
MA (1) MA24655A1 (en)
PA (1) PA8459501A1 (en)
PE (1) PE117199A1 (en)
TN (1) TNSN98175A1 (en)
WO (1) WO1999015166A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (en) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintics to prevent parasitic infections in humans and animals
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
WO2018226512A1 (en) * 2017-06-06 2018-12-13 Merck Sharp & Dohme Corp. Long-action implant for treatment of infectious diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
GT199800149A (en) 2000-03-15
PE117199A1 (en) 1999-11-20
AR013509A1 (en) 2000-12-27
TNSN98175A1 (en) 2005-03-15
MA24655A1 (en) 1999-04-01
JP2001517622A (en) 2001-10-09
WO1999015166A1 (en) 1999-04-01
AP9801350A0 (en) 2000-03-17
AU9742298A (en) 1999-04-12
BR9812385A (en) 2000-09-12
EP1014970A1 (en) 2000-07-05
CA2304283A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
ES2190075T3 (en) SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULFOALQUIL-ETER-CYCLODEXTRINE AND A THERAPEUTIC AGENT.
PT1140018E (en) POLYOL / OIL SUSPENSIONS FOR SUSTAINED PROTEIN LIBERATION
CY1108532T1 (en) UNIONS AND COMPOSITIONS FOR PROVIDING ACTIVE AGENTS
BR0112054A (en) Micelle-forming composition, and methods for administration and protection of a therapeutic agent
CR7140A (en) ANTRANILAMIDS WITH A SIDE CHAIN OF A HETEROARYLSULFONIL, METHODS FOR THE PRODUCTION OF THE SAME, ITS USE AS A MEDICINAL OR DIAGNOSTIC AGENT AND PHARMACEUTICAL PREPARATIONS CONTAINED IN SUCH COMPOUNDS
DK0994710T4 (en) Pharmaceutical compositions for oral administration comprising a benzylhydrylpiperazine and a cyclodextrin
PA8459501A1 (en) PARASITICIDE FORMULATIONS
GT199800101A (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING A DERIVATIVE OF BENZOFURANE.
ES2195189T3 (en) BENZONAFTIRIDINES AS BRONCHIAL THERAPEUTIC AGENTS.
CO4700420A1 (en) TRANSDERMIC FORMULATION
AR032872A1 (en) COMPOSITION TO CLEAR THE SKIN AND APPLICATION METHOD
PT1079839E (en) THERAPEUTIC AGENT AGAINST CONSTIPACOES CONTAINING ISOMALTOSIS AS ACTIVE INGREDIENT
CU23113A3 (en) REPRESSION OF ARTROPODES IN ANIMALS
ES2171669T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING THIAGABINE HYDROCLORIDE AND ITS PREPARATION PROCEDURE.
ES2158094T3 (en) ADDITION SALTS OF COMPOUND ACID OF 2,3,4,5-TETRAHIDRO-1H-3-BENZAZEPINA.
ITMI20031714A1 (en) FORMATIONS FOR ANTITUMORAL ACTION.
CO4750591A1 (en) INSECT FIGHTING PROCEDURE
BR0311479A (en) Anthelmintic and insecticidal thiophene derivatives
ES2191426T3 (en) STABLE COMPOSITIONS THAT INCLUDE LEVOSIMENDAN AND ALGINIC ACID.
MX9100441A (en) PROCEDURE FOR MAKING ORAL SOLID PREPARATIONS, WHICH CONTAIN IFOSFAMIDE AS AN ACTIVE AGENT
DE60013111D1 (en) ORAL CARE COMPOSITION
ES2161913T3 (en) TRINUCLEAR CATIONIC COMPLEXES OF PLATINO THAT HAVE AN ANTITUMORAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
CO4940379A1 (en) ANTIMICROBIAL COMPOSITIONS TO LEAVE THEM ON THE SKIN CONTAINING ANTIMICROBIAL
ES2196171T3 (en) ANTI-FOOD AGENTS OF TIOXANTENONE LIOFILIZED.
ES2140673T3 (en) HELICOBACTER PYLORI CATALASE BASED IMMUNIZING COMPOSITION.